drugset / Trial / NCT01665417
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to compare the efficacy and safety of first-line icotinib treatment and first-line chemotherapy followed by maintenance treatment with icotinib.
Timeline
- Start
- 2012-08
- Primary completion
- 2017-07
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |
| Subject | Icotinib | Small molecule | 125 mg | Oral |
| Subject | Oxaliplatin | Small molecule | 500 mg/m2 | — |